Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome

Masters Speciality Pharma, a UK-headquartered pharmaceutical company specialising in the global distribution of high-quality, life-changing medicines, today announces the recent launch in Brazil of Neuropad®, a rapid and reliable screening test for diabetic foot syndrome.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH